Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-09-05 5:03 pm Purchase |
2023-08-24 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
CONTINENTAL GENERAL INSURANCE CO | 3,693,981 6.400% |
3,693,981 (New Position) |
Filing History |
| 2023-06-27 08:20 am Unchanged |
2023-06-27 | 13D | Paratek Pharmaceuticals, Inc. PRTK |
NexPoint Real Estate Opportunities LLC | 6,692,447 11.690% |
0 (Unchanged) |
Filing History |
| 2023-03-30 4:30 pm Purchase |
2023-03-16 | 13D | Paratek Pharmaceuticals, Inc. PRTK |
NexPoint Real Estate Opportunities LLC | 6,692,447 11.690% |
2,822,250 (+72.92%) |
Filing History |
| 2023-03-20 08:08 am Sale |
2023-03-16 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
HIRSCHMAN ORIN | 2,802,115 4.900% |
-1,354,776 (-32.59%) |
Filing History |
| 2023-02-15 07:18 am Purchase |
2022-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
HIRSCHMAN ORIN | 4,156,891 7.500% |
269,719 (+6.94%) |
Filing History |
| 2023-02-13 3:40 pm Sale |
2022-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
LYTTON LAURENCE W | 459,961 0.800% |
-2,750,591 (-85.67%) |
Filing History |
| 2023-01-20 4:15 pm Purchase |
2022-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
NexPoint Real Estate Opportunities LLC | 3,870,197 6.970% |
3,870,197 (New Position) |
Filing History |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
BLACKROCK INC BLK |
869,224 1.600% |
-2,108,456 (-70.81%) |
Filing History |
| 2022-07-07 2:58 pm Purchase |
2022-07-05 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
HIRSCHMAN ORIN | 3,887,172 7.700% |
1,067,105 (+37.84%) |
Filing History |
| 2022-05-18 4:47 pm Purchase |
2022-05-09 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
LYTTON LAURENCE W | 3,210,552 5.900% |
3,210,552 (New Position) |
Filing History |
| 2022-03-11 4:15 pm Purchase |
2021-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
DONDERO JAMES D | 2,892,197 5.700% |
2,892,197 (New Position) |
Filing History |
| 2022-03-09 08:10 am Purchase |
2022-02-09 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
HIRSCHMAN ORIN | 2,820,067 5.600% |
2,820,067 (New Position) |
Filing History |
| 2022-02-11 08:19 am Sale |
2021-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,239,937 4.270% |
-237,547 (-9.59%) |
Filing History |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
BLACKROCK INC BLK |
2,977,680 5.900% |
-469,649 (-13.62%) |
Filing History |
| 2021-02-12 4:47 pm Purchase |
2020-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
NEXPOINT ASSET MANAGEMENT L.P. | 2,301,555 5.000% |
2,301,555 (New Position) |
Filing History |
| 2021-02-09 08:20 am Purchase |
2020-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,477,484 5.150% |
98,553 (+4.14%) |
Filing History |
| 2021-01-29 5:22 pm Purchase |
2020-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
BLACKROCK INC BLK |
3,447,329 7.600% |
1,123,417 (+48.34%) |
Filing History |